CPL LIFE SCIENCES
SWITZERLAND
LIFE SCIENCES STAFFING INSIGHTS AND TRENDS
WE EXPECT TO SEE ROLES IN DATA SCIENCE GROW IN 2024, PARTICULARY IN ROLES INVOLVING DATA COLLECTION AND ANALYSIS.
2023: In Review Switzerland is home to a wealth of important activity in the life sciences sector, with a unique science ecosystem of organizations, languages, and legislations. This creates a complicated and exciting environment for exchanging information and ideas, leading to significant innovation in the region. Despite this, since the start of 2023 we have witnessed a significant decline in jobs in life sciences sectors focused on drug/device discovery, development and commercialisation.
There are a number of factors contributing to this, including:
The worldwide economic climate and financial concerns which have shaped every sector’s fate over the past 12 months+. Investors and/or funding streams delaying or just not happening, with cash runways for earlier stage bio/med tech impacted. This has led to increased difficulty driving product cycles and bringing products to market, with many companies having to refine portfolio’s and restructure/re-strategise. A surge of recruitment over 2021-2022 after the Covid pandemic ‘stand-still’, particularly for clinical studies that stalled then needed to catch up, exacerbated salary increases and skills shortages and delayed product pipelines. Delays in regulatory submissions, applications and reimbursement processes; caused delays in product approval and launches, the knock on effect was employers taking a more careful approach to recruiting and only hiring critical roles and spending within budgets.
PAGE | 06
Made with FlippingBook flipbook maker